BNTX BioNTech SE American Depositary Share Loading... : Bullish and Bearish Analyst Opinions

From PFE earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
14:00
May 05
Dave Denton CFO, Pfizer, Inc. PFE Q1 FY26 call
Pfizer's gross margin commentary confirms ongoing 50-50 profit share with BioNTech for Comirnaty, underscoring alignment of interests and shared financial exposure.
BNTX
HIGH
15:00
Feb 03
Dave Denton CFO, Pfizer, Inc. PFE Q4 FY25 call
Pfizer's COVID product partnership with BioNTech continues to be a significant driver of reported financials, with a 50-50 profit split on Comirnaty, though the revenue decline for COVID products is factored into guidance.
BNTX
HIGH

About BNTX Analyst Coverage

Buzzberg tracks BNTX (BioNTech SE American Depositary Share) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Dave Denton.